Amgen Inc. (AMGN) Financial Statements (2025 and earlier)

Company Profile

Business Address ONE AMGEN CENTER DRIVE
THOUSAND OAKS, CA 91320
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10,9449,3058,03710,6478,91129,304
Cash and cash equivalent10,9447,6297,9896,2666,0376,945
Short-term investments  1,676484,3812,87422,359
Receivables7,2685,5634,8954,5254,0573,580
Inventory, net of allowances, customer advances and progress billings9,5184,9304,0863,8933,5842,940
Inventory9,5184,9304,0863,8933,5842,940
Other current assets2,6022,3882,3672,0791,8881,794
Total current assets:30,33222,18619,38521,14418,44037,618
Noncurrent Assets
Property, plant and equipment5,9415,4275,1844,8894,9284,958
Intangible assets, net (including goodwill)51,27031,60930,07231,27634,11622,142
Goodwill18,62915,52914,89014,68914,70314,699
Intangible assets, net (excluding goodwill)32,64116,08015,18216,58719,4137,443
Other noncurrent assets9,6115,8996,5245,6392,2231,698
Total noncurrent assets:66,82242,93541,78041,80441,26728,798
TOTAL ASSETS:97,15465,12161,16562,94859,70766,416
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities16,94914,09612,09711,5629,8829,069
Accounts payable1,5901,5721,3661,4211,3711,207
Accrued liabilities15,35912,52410,73110,1418,5117,862
Debt1,4431,59187912,9534,419
Total current liabilities:18,39215,68712,18411,65312,83513,488
Noncurrent Liabilities
Long-term debt and lease obligation63,17037,35433,22232,89527,33829,510
Long-term debt, excluding current maturities63,17037,35433,22232,89526,95029,510
Liabilities, other than long-term debt9,3608,4199,0598,9919,64310,918
Deferred tax liabilities, net864
Deferred income tax liabilities2,354    
Liability for uncertainty in income taxes4,6805,7576,5946,9688,0378,770
Other liabilities2,3262,6622,4652,0231,6061,284
Operating lease, liability     388
Total noncurrent liabilities:72,53045,77342,28141,88636,98140,428
Total liabilities:90,92261,46054,46553,53949,81653,916
Equity
Equity, attributable to parent, including:6,2323,6616,7009,4099,67312,500
Accumulated other comprehensive loss(289)(231)(796)(985)(528)(769)
Accumulated deficit(26,549)(28,622)(24,600)(21,408)(21,330)(17,977)
Other undisclosed equity, attributable to parent33,07032,51432,09631,80231,53131,246
Total equity:6,2323,6616,7009,4099,67312,500
Other undisclosed liabilities and equity     218 
TOTAL LIABILITIES AND EQUITY:97,15465,12161,16562,94859,70766,416

Income Statement (P&L) ($ in millions)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues28,19026,32325,97925,42423,36223,747
Cost of revenue
(Cost of Product and Service Sold)
(8,451)(6,406)(6,454)(6,159)(4,356)(4,101)
Gross profit:19,73919,91719,52519,26519,00619,646
Operating expenses(11,842)(10,351)(11,886)(10,126)(9,332)(9,383)
Operating income:7,8979,5667,6399,1399,67410,263
Nonoperating income (expense)2,833(814)259256753674
Investment income, nonoperating1,200     
Interest and debt expense(2,875)(1,406)(1,197)(1,262)(1,289)(1,392)
Income from continuing operations before equity method investments, income taxes:7,8557,3466,7018,1339,1389,545
Income (loss) from equity method investments(11)     
Other undisclosed income (loss) from continuing operations before income taxes11     
Income from continuing operations before income taxes:7,8557,3466,7018,1339,1389,545
Income tax expense(1,138)(794)(808)(869)(1,296)(1,151)
Income from continuing operations:6,7176,5525,8937,2647,8428,394
Income before gain (loss) on sale of properties:5,8937,2647,8428,394
Net income available to common stockholders, diluted:6,7176,5525,8937,2647,8428,394

Comprehensive Income ($ in millions)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income:6,7176,5525,8937,2647,8428,394
Other comprehensive income (loss) (58)565189(457)241(81)
Comprehensive income:6,6597,1176,0826,8078,0838,313
Other undisclosed comprehensive income, net of tax, attributable to parent      
Comprehensive income, net of tax, attributable to parent:6,6597,1176,0826,8078,0838,313

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: